A Phase 2, Multicenter, Placebo-controlled, Double-blind, Randomized, Parallel-group Trial to Investigate the Efficacy and Safety of Orally Administered Tolvaptan (OPC-41061) in Patients With Chronic Renal Failure Undergoing Hemodialysis or Hemodiafiltration

Category Primary study
Registry of TrialsJapan Primary Registry Network
Year 2014
This article has no abstract
Epistemonikos ID: f7296dd48cc37dae04d57b4c271d840413cf90f1
First added on: Apr 16, 2025